Craft

AbbVie

Stock Price

$189.4

2024-10-29

Market Capitalization

$335 B

2024-10-29

Revenue

$61.2 B

FY, 2025

AbbVie Summary

Company Summary

Overview
AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. Its products include masks, thyroid tablets, oral suspensions, gels, capsules, injections, emulsions, implants, etc. The company focuses on immunology, oncology, neuroscience, eye care, and other areas.
Type
Public
Status
Active
Founded
2013
HQ
North Chicago, IL, US | view all locations
Website
https://www.abbvie.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Richard A. Gonzalez

    Richard A. Gonzalez, Chairman of the Board and Chief Executive Officer

  • Rae L. Livingston

    Rae L. Livingston, Chief Equity Officer

  • Scott T. Reents

    Scott T. Reents, Executive Vice President, Chief Financial Officer

  • Timothy J. Richmond

    Timothy J. Richmond, Executive Vice President, Chief Human Resources Officer

Operating MetricsView all

Countries

70

FY, 2022

Manufacturing Facilities

19

FY, 2022

Research and Development Centers

14

FY, 2020

LocationsView all

80 locations detected

  • North Chicago, IL HQ

    United States

    1 North Waukegan Road

  • Cambridge, MA

    United States

    200 Sidney St

  • Mettawa, IL

    United States

    26525 Riverwoods Blvd

  • North Chicago, IL

    United States

    1401 Sheridan Rd

  • South San Francisco, CA

    United States

    1000 Gateway Blvd

  • Washington, DC

    United States

    1399 New York Ave NW #600

and 74 others

AbbVie Financials

Summary Financials

Revenue (Q1, 2026)
$15.0B
Gross profit (Q1, 2026)
$10.8B
Net income (Q1, 2026)
$697.0M
Cash (Q1, 2026)
$9.4B
EBIT (Q1, 2026)
$4.0B
Enterprise value
$398.5B

Footer menu